PureTech Health announces a $100M tender offer for ordinary shares at 250p/share, closing on 20 June 2024.
PureTech Health, a clinical-stage biotherapeutics company, announced a proposed $100 million tender offer. The offer opens on 20 May 2024, and the Company will buy up to $100m worth of ordinary shares at 250 pence per share. The tender offer will close on 20 June 2024 for ordinary shares and on 18 June for ADSs. The company aims to return capital to shareholders through this initiative.
May 20, 2024
5 Articles